Europe Orthobiologics Market By Product (Demineralized Bone Matrix {DBM}, Allograft, Bone Morphogenetic Protein {BPM}, Viscosupplementation Products, Synthetic Bone Substitutes and Others), Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial and Dental Applications), Type (Knee, Ankle, Hip, Wrist and Shoulder, Spine and Others), End User (Hospitals and Ambulatory Centres, Research and Academic Institute, and Dental Clinics), Country (Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland and Rest Of Europe) Industry Trends and Forecast to 2028.
Market Analysis and Insights of Europe Orthobiologics Market
Data Bridge Market Research analyses that the Europe orthobiologics market will exhibit a CAGR of around 5.17% for the forecast period of 2021-2028. Rising prevalence of obese and overweight population, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies, and rising expenditure on the healthcare infrastructure development especially in the developing economies are the major factors attributable to the growth of orthobiologics market.
Also known as regenerative cellular therapy, orthobiologics is used in regeneration of damaged or wounded joints and tissues, tendons and ligaments. Orthobiologics assists in tissue healing and helps in minimizing the effect of degenerative disease.
Upsurge in the prevalence of a wide range of sports related injuries globally is one of the major factors fostering the growth of the market. Rising focus on the healthcare technological advancements coupled with growing prevalence for minimally invasive surgeries is another market growth determinant. Rising number of hospitals and diagnostic centres and surging incidences of spinal disorders will further generate lucrative market growth opportunities.
However, high costs associated with the orthopaedic implants and unfavourable regulatory scenario will derail the market growth rate. Lack of medical experts especially in the developing and underdeveloped economies and stringent regulations imposed by the government on product approvals will further pose challenges for the market. Also, post-surgery complications will also hamper the market growth rate.
This orthobiologics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on orthobiologics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Europe Orthobiologics Market Scope and Market Size
The orthobiologics market is segmented on the basis of product, application, type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, orthobiologics market is segmented into demineralized bone matrix {DBM}, allograft, bone morphogenetic protein {BPM}, viscosupplementation products and synthetic bone substitutes and others.
- On the basis of application, the orthobiologics market is segmented into osteoarthritis and degenerative arthritis, spinal fusion, fracture recovery, soft tissue injuries, and maxillofacial and dental applications.
- On the basis of type, the orthobiologics market is segmented into knee, ankle, hip, wrist and shoulder, spine, and others.
- On the basis of end user, the orthobiologics market is segmented into hospitals and ambulatory centers, research and academic institute, and dental clinics.
Europe Orthobiologics Market Country Level Analysis
The orthobiologics market is analysed and market size insights and trends are provided by country, product, application, type and end user as referenced above.
The countries covered in the orthobiologics market report are Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland and Rest of Europe.
The country section of the orthobiologics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The orthobiologics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for orthobiologics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the orthobiologics market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Europe Orthobiologics Market Share Analysis
The orthobiologics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to orthobiologics market.
The major players covered in the orthobiologics market report are Baxter, CONMED Corporation, DePuy Synthes, Exactech, Inc., Integra LifeSciences Corporation, Medtronic, NuVasive, Inc., RTI Surgical Holdings, Inc., Sanofi, Smith & Nephew, Stryker, Zimmer Biomet, SINTX Technologies, Inc., AlloSource among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-